Similar articles for PMID: 30853359

Year	Number of Results
2000	1
2001	1
2002	1
2003	2
2004	1
2005	2
2006	1
2007	2
2008	5
2009	9
2010	5
2011	8
2012	10
2013	10
2014	21
2015	18
2016	12
2017	22
2018	25
2019	29
2020	22
2021	22
2022	27
2023	16
2024	0

1

HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trial.

Wright TC Jr, Parvu V, Stoler MH, Kodsi S, Eckert K, Yanson K, Cooper CK. Wright TC Jr, et al. Gynecol Oncol. 2019 May;153(2):259-265. doi: 10.1016/j.ygyno.2019.02.016. Epub 2019 Mar 7. Gynecol Oncol. 2019. PMID: 30853359 Free article. Clinical Trial.

2

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. C Kitchener H, et al. Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230. Health Technol Assess. 2014. PMID: 24762804 Free PMC article. Clinical Trial.

3

Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.

Stoler MH, Wright TC Jr, Parvu V, Yanson K, Cooper CK, Andrews J. Stoler MH, et al. Gynecol Oncol. 2019 Apr;153(1):26-33. doi: 10.1016/j.ygyno.2018.12.024. Epub 2019 Jan 10. Gynecol Oncol. 2019. PMID: 30638767 Free article.

4

The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.

Munro A, Gillespie C, Cotton S, Busby-Earle C, Kavanagh K, Cuschieri K, Cubie H, Robertson C, Smart L, Pollock K, Moore C, Palmer T, Cruickshank ME. Munro A, et al. BJOG. 2017 Aug;124(9):1394-1401. doi: 10.1111/1471-0528.14563. Epub 2017 Mar 9. BJOG. 2017. PMID: 28102931 Free article.

5

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.

Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett CJ, Farnsworth A, Tan J, Wrede CD, Castle PE, Saville M. Canfell K, et al. PLoS Med. 2017 Sep 19;14(9):e1002388. doi: 10.1371/journal.pmed.1002388. eCollection 2017 Sep. PLoS Med. 2017. PMID: 28926579 Free PMC article. Clinical Trial.

6

The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.

Stoler MH, Wright TC Jr, Parvu V, Vaughan L, Yanson K, Eckert K, Karchmer T, Kodsi S, Cooper CK. Stoler MH, et al. Gynecol Oncol. 2018 Jun;149(3):498-505. doi: 10.1016/j.ygyno.2018.04.007. Epub 2018 Apr 19. Gynecol Oncol. 2018. PMID: 29681462 Free article.

7

Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.

Wright TC Jr, Stoler MH, Parvu V, Yanson K, Cooper C, Andrews J. Wright TC Jr, et al. Gynecol Oncol. 2019 Aug;154(2):360-367. doi: 10.1016/j.ygyno.2019.05.012. Epub 2019 May 31. Gynecol Oncol. 2019. PMID: 31160073 Free article.

8

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.

Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN, Schussler J, Schiller JT, Lowy DR, Sierra MS, Carvajal L, Kreimer AR; Costa Rica HPV Vaccine Trial Group. Shing JZ, et al. Lancet Oncol. 2022 Jul;23(7):940-949. doi: 10.1016/S1470-2045(22)00291-1. Epub 2022 Jun 13. Lancet Oncol. 2022. PMID: 35709811 Free PMC article. Clinical Trial.

9

[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].

Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF. Luo HX, et al. Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232-238. doi: 10.3760/cma.j.issn.0253-3766.2018.03.015. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29575846 Chinese.

10

Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.

Velentzis LS, Sitas F, O'Connell DL, Darlington-Brown J, Egger S, Sinha R, Banks E, Frazer IH, Canfell K. Velentzis LS, et al. BMC Infect Dis. 2014 Dec 21;14:3861. doi: 10.1186/s12879-014-0676-z. BMC Infect Dis. 2014. PMID: 25528152 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

244 results

Results by year